<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a 60-year-old man with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) whose aortic valve was replaced successfully </plain></SENT>
<SENT sid="1" pm="."><plain>He suffered from <z:hpo ids='HP_0002094'>dyspnea</z:hpo> on exertion and was confirmed by echocardiography and cardiac catheterization to have severe <z:hpo ids='HP_0001650'>aortic stenosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A peripheral blood examination showed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and a bone marrow examination showed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with a subtype of <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts </plain></SENT>
<SENT sid="3" pm="."><plain>His preoperative neutrophil count was 468/mm3, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> 9.8 g/dl, and platelet count 27,000/mm3 </plain></SENT>
<SENT sid="4" pm="."><plain>We conducted aortic valve replacement (AVR) using a bioprosthesis in July 2001 </plain></SENT>
<SENT sid="5" pm="."><plain>Pre- and postoperatively, we injected granulocyte colony-stimulating factor to keep the neutrophil count at 2,000/mm3 or more </plain></SENT>
<SENT sid="6" pm="."><plain>We also transfused platelet concentrate and infused <z:chebi fb="0" ids="48669">tranexamic acid</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Despite potential risks of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:mp ids='MP_0001914'>bleeding</z:mp>, the AVR involved no significant complications </plain></SENT>
<SENT sid="8" pm="."><plain>Careful preoperative planning thus plays an important role in managing such cases </plain></SENT>
</text></document>